Posts

Cypris Therapeutics Launches with Revolutionary Synthetic Chemistry Technology to Combat Resistant Cancers

Cypris Therapeutics, a pioneering drug discovery company, has officially launched following a breakthrough in synthetic chemistry technology. This innovation enables the development of novel...

The AI Revolution in Drug Discovery: Early Evidence and Implications

Drug discovery has long been an arduous journey, marked by high costs, extensive timelines, and significant uncertainty. Despite the latest experimental technologies, many discovery...

Takeda Presents Positive Phase 2b Study Results for Mezagitamab (TAK-079) in Treating Primary Immune Thrombocytopenia (ITP)

Takeda today announced positive findings from its Phase 2b, randomized, double-blind, placebo-controlled trial evaluating the safety, tolerability, and efficacy of mezagitamab (TAK-079) in patients...

Breaking New Ground in Genomics

In a groundbreaking development, researchers have unveiled a new framework called SQUID (Surrogate Quantitative Interpretability for Deepnets), poised to revolutionize the field of genomic...

Brenus Pharma Presents Study Design for “BreAK-CRC” at ASCO Annual Meeting

Brenus Pharma, a French biotech company developing the innovative “Stimulated-Tumor-Cell” (STC) discovery platform, has unveiled the study design for its first-in-human trial, “BreAK-CRC,” featuring...

Athos Therapeutics Selects Vultr Cloud GPU for Advanced AI Model Training and Inference

Vultr, the world's largest privately-held cloud computing platform, proudly announces that Athos Therapeutics, Inc. ("Athos"), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU...

Marea Therapeutics Launches with $190 Million in Funding to Revolutionize Cardiometabolic Disease Treatment

Marea Therapeutics, a clinical-stage biotechnology company incubated by Third Rock Ventures, has officially launched with a combined $190 million from Series A and B...

Alphawave Semi Announces Successful Tape-Out of Industry’s First Off-the-Shelf Multi-Protocol I/O Connectivity Chiplet on TSMC’s 7nm Process

Alphawave Semi (LSE: AWE), a global leader in high-speed connectivity and compute silicon, proudly announces the successful tape-out of the industry’s first off-the-shelf multi-protocol...

Delve Bio Announces Clinical Data on the Use of Metagenomic Next-Generation Sequencing (mNGS) to Identify Pathogens Causing Central Nervous System Infections

Delve Bio and UCSF Unveil Pioneering mNGS Study at American Society of Microbiology Microbe Conference Delve Bio, a leader in metagenomic next-generation sequencing (mNGS) for...

Genentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced compelling results from its Phase III STARGLO study of Columvi®...